SS
Shaileshkumar Shantaram Gadhave
About Shaileshkumar Shantaram Gadhave
Data last updated:
Shaileshkumar Shantaram Gadhave is a Designated Partner at Klarvision Pharma Llp (since 2019). The companies operate in Business Services. Earlier, Shaileshkumar Shantaram Gadhave was a Director at Icognition Insights Private Limited (from 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Klarvision Pharma Llp AAO-6754 | Designated Partner | 28 Mar 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Icognition Insights Private Limited U74999PN2020PTC194952 | Director | 13 Oct 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shaileshkumar Shantaram Gadhave
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vaibhav Pandit Shinde | 08403653 | Klarvision Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shaileshkumar Shantaram Gadhave
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shaileshkumar Shantaram Gadhave
Shaileshkumar Shantaram Gadhave currently holds 1 directorship: Klarvision Pharma Llp (Designated Partner, since 28 Mar 2019).
Shaileshkumar Shantaram Gadhave was first appointed on 28 Mar 2019 as Designated Partner at Klarvision Pharma Llp. The most recent appointment on record is 13 Oct 2020 at Icognition Insights Private Limited.
Shaileshkumar Shantaram Gadhave held 1 earlier board appointment: Icognition Insights Private Limited (Director, from 13 Oct 2020).
The current boards of Shaileshkumar Shantaram Gadhave's companies include Vaibhav Pandit Shinde (Klarvision Pharma Llp).